GKB Ophthalmics Limited (BOM:533212)

GKB Ophthalmics Statistics

Total Valuation

GKB Ophthalmics has a market cap or net worth of INR 383.34 million. The enterprise value is 434.05 million.

Market Cap	383.34M
Enterprise Value	434.05M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

GKB Ophthalmics has 5.04 million shares outstanding. The number of shares has decreased by -0.04% in one year.

Current Share Class	5.04M
Shares Outstanding	5.04M
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	72.25%
Owned by Institutions (%)	5.51%
Float	1.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.35
PB Ratio	0.68
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.16
EV / Sales	0.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.78

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.26.

Current Ratio	1.59
Quick Ratio	0.64
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-2.60
Interest Coverage	-2.48

Financial Efficiency

Return on equity (ROE) is -11.74% and return on invested capital (ROIC) is -5.00%.

Return on Equity (ROE)	-11.74%
Return on Assets (ROA)	-3.06%
Return on Invested Capital (ROIC)	-5.00%
Return on Capital Employed (ROCE)	-9.34%
Revenue Per Employee	6.73M
Profits Per Employee	-434,864
Employee Count	162
Asset Turnover	0.91
Inventory Turnover	1.62

Taxes

In the past 12 months, GKB Ophthalmics has paid 3.53 million in taxes.

Income Tax	3.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.16% in the last 52 weeks. The beta is 0.33, so GKB Ophthalmics's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-30.16%
50-Day Moving Average	74.35
200-Day Moving Average	86.16
Relative Strength Index (RSI)	45.03
Average Volume (20 Days)	1,887

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GKB Ophthalmics had revenue of INR 1.09 billion and -70.45 million in losses. Loss per share was -13.98.

Revenue	1.09B
Gross Profit	355.42M
Operating Income	-58.70M
Pretax Income	-67.26M
Net Income	-70.45M
EBITDA	-27.83M
EBIT	-58.70M
Loss Per Share	-13.98

Balance Sheet

The company has 138.23 million in cash and 144.96 million in debt, giving a net cash position of -6.74 million or -1.34 per share.

Cash & Cash Equivalents	138.23M
Total Debt	144.96M
Net Cash	-6.74M
Net Cash Per Share	-1.34
Equity (Book Value)	564.37M
Book Value Per Share	103.17
Working Capital	370.04M

Cash Flow

In the last 12 months, operating cash flow was -34.30 million and capital expenditures -21.47 million, giving a free cash flow of -55.77 million.

Operating Cash Flow	-34.30M
Capital Expenditures	-21.47M
Free Cash Flow	-55.77M
FCF Per Share	-11.06

Margins

Gross margin is 32.61%, with operating and profit margins of -5.39% and -6.46%.

Gross Margin	32.61%
Operating Margin	-5.39%
Pretax Margin	-6.17%
Profit Margin	-6.46%
EBITDA Margin	-2.55%
EBIT Margin	-5.39%
FCF Margin	n/a

Dividends & Yields

GKB Ophthalmics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.04%
Shareholder Yield	0.04%
Earnings Yield	-18.38%
FCF Yield	-14.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3